rs886044398
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001849.4(COL6A2):c.1751del(p.Pro584LeufsTer12) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
COL6A2
NM_001849.4 frameshift
NM_001849.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.11
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 21-46124895-GC-G is Pathogenic according to our data. Variant chr21-46124895-GC-G is described in ClinVar as [Pathogenic]. Clinvar id is 290249.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr21-46124895-GC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.1751del | p.Pro584LeufsTer12 | frameshift_variant | 23/28 | ENST00000300527.9 | NP_001840.3 | |
COL6A2 | NM_058174.3 | c.1751del | p.Pro584LeufsTer12 | frameshift_variant | 23/28 | ENST00000397763.6 | NP_478054.2 | |
COL6A2 | NM_058175.3 | c.1751del | p.Pro584LeufsTer12 | frameshift_variant | 23/28 | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.1751del | p.Pro584LeufsTer12 | frameshift_variant | 23/28 | 1 | NM_001849.4 | ENSP00000300527 | P1 | |
COL6A2 | ENST00000397763.6 | c.1751del | p.Pro584LeufsTer12 | frameshift_variant | 23/28 | 5 | NM_058174.3 | ENSP00000380870 | ||
COL6A2 | ENST00000409416.6 | c.1751del | p.Pro584LeufsTer12 | frameshift_variant | 22/27 | 5 | ENSP00000387115 | |||
COL6A2 | ENST00000413758.1 | c.374del | p.Pro125LeufsTer12 | frameshift_variant | 8/11 | 3 | ENSP00000395751 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 34
GnomAD4 exome
Cov.:
34
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Bethlem myopathy 1A Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 07, 2022 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 290249). This variant has not been reported in the literature in individuals affected with COL6A2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro584Leufs*12) in the COL6A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL6A2 are known to be pathogenic (PMID: 19884007, 20976770). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 05, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at